These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies. Xie L, Wei W, Pan C, Baser O. J Med Econ; 2013 Sep; 16(9):1137-45. PubMed ID: 23859434 [Abstract] [Full Text] [Related]
26. Factors Associated with Diabetes-Related Clinical Inertia in a Managed Care Population and Its Effect on Hemoglobin A1c Goal Attainment: A Claims-Based Analysis. Ruiz-Negrón N, Wander C, McAdam-Marx C, Pesa J, Bailey RA, Bellows BK. J Manag Care Spec Pharm; 2019 Mar; 25(3):304-313. PubMed ID: 30816810 [Abstract] [Full Text] [Related]
27. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications. Axon DR, Vaffis S, Chinthammit C, Lott BE, Taylor AM, Pickering M, Black H, Warholak T, Campbell PJ. J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989 [Abstract] [Full Text] [Related]
30. Lowering Cost Share May Improve Rates of Home Glucose Monitoring Among Patients with Diabetes Using Insulin. Xie Y, Agiro A, Bowman K, DeVries A. J Manag Care Spec Pharm; 2017 Aug; 23(8):884-891. PubMed ID: 28737991 [Abstract] [Full Text] [Related]
31. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs. Bron M, Marynchenko M, Yang H, Yu AP, Wu EQ. Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122 [Abstract] [Full Text] [Related]
34. Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study. Mody R, Huang Q, Yu M, Patel H, Zhang X, Wang L, Grabner M. BMJ Open Diabetes Res Care; 2019 Jan; 7(1):e000884. PubMed ID: 31875137 [Abstract] [Full Text] [Related]
40. Comparison of medication adherence and associated health care costs after introduction of pioglitazone treatment in African Americans versus all other races in patients with type 2 diabetes mellitus: a retrospective data analysis. Shenolikar RA, Balkrishnan R, Camacho FT, Whitmire JT, Anderson RT. Clin Ther; 2006 Aug; 28(8):1199-1207. PubMed ID: 16982297 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]